Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question
Burzykowski, Tomasz, Saad, Everardo D., Buyse, MarcLanguage:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2016.3941
Date:
November, 2016
File:
PDF, 37 KB
english, 2016